Liberum Capital reaffirmed their buy rating on shares of Reckitt Benckiser Group (LON:RB) in a research note released on Monday. Liberum Capital currently has a GBX 8,000 ($108.49) price target on the stock.

Other equities analysts also recently issued research reports about the stock. Berenberg Bank reaffirmed a buy rating and set a GBX 8,500 ($115.27) price target on shares of Reckitt Benckiser Group in a research note on Monday, October 9th. Whitman Howard reissued a buy rating and issued a GBX 9,000 ($122.05) target price on shares of Reckitt Benckiser Group in a research note on Monday, October 16th. Deutsche Bank reissued a buy rating and issued a GBX 8,500 ($115.27) target price on shares of Reckitt Benckiser Group in a research note on Thursday, October 12th. Morgan Stanley set a £100 ($135.61) target price on shares of Reckitt Benckiser Group and gave the company a buy rating in a research note on Wednesday, October 11th. Finally, JPMorgan Chase & Co. set a GBX 7,500 ($101.71) target price on shares of Reckitt Benckiser Group and gave the company a buy rating in a research note on Wednesday, January 3rd. Two research analysts have rated the stock with a sell rating, twelve have issued a hold rating and nine have assigned a buy rating to the company’s stock. Reckitt Benckiser Group currently has a consensus rating of Hold and an average price target of GBX 7,619.09 ($103.32).

Reckitt Benckiser Group (LON RB) opened at GBX 6,802 ($92.24) on Monday. The firm has a market cap of $47,860.00 and a P/E ratio of 2,274.92. Reckitt Benckiser Group has a one year low of GBX 6,299 ($85.42) and a one year high of GBX 8,110.43 ($109.99).

In other Reckitt Benckiser Group news, insider Adrian Nevil Hennah purchased 2,285 shares of the firm’s stock in a transaction dated Wednesday, November 8th. The stock was acquired at an average cost of GBX 6,567 ($89.06) per share, with a total value of £150,055.95 ($203,493.29). Also, insider Christopher Sinclair purchased 2,800 shares of the firm’s stock in a transaction dated Wednesday, November 1st. The stock was acquired at an average cost of GBX 6,597 ($89.46) per share, with a total value of £184,716 ($250,496.34).

WARNING: This report was first posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this report on another website, it was stolen and reposted in violation of United States and international copyright & trademark law. The original version of this report can be viewed at https://theolympiareport.com/2018/01/18/reckitt-benckiser-groups-rb-buy-rating-reiterated-at-liberum-capital-2.html.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.